Glucotrack

RUTHERFORD, N.J., May 7, 2026 Glucotrack, Inc. announced the submission of an Investigational Device Exemption (IDE) application to the...

RUTHERFORD, N.J., March 27, 2026 GlucoTrack announced plans to submit an Investigational Device Exemption (IDE) application to the U.S....

Rutherford, New Jersey | December 30, 2025 — Glucotrack, Inc., a medical technology company focused on diabetes care innovation,...